Investing Profile

Dmitrij Hristodorov

InvestorVC
General Partner at Forbion
forbion.comMunich, Germany
Photo of Dmitrij Hristodorov, General Partner at Forbion

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4898 CONNECTIONS
Hotmail Network
4898 CONNECTIONS
Hotmail Network
4898 CONNECTIONS
Hotmail Network
4898 CONNECTIONS
RWTH Aachen University Network
25 CONNECTIONS
cb
Forbion General Partner
$100K - $5.0M
$1.5M
12
CompanyStageDateRound SizeTotal Raised
Beacon Therapeutics
Series CJan 2026$75M
Series BJun 2024$170M
$250M
Co-investors: Wouter Joustra (Forbion)
AAVantgarde Bio
Series BNov 2025$140M
Series AJun 2023$65M
$210M
Co-investors: Paola Pozzi (Sofinnova Partners), Graziano Seghezzi (Sofinnova Partners), David Steinberg (Longwood Fund), Jason Rhodes (Atlas Venture)
Progentos Therapeutics
Series AMay 2024$65M
$65M
Co-investors: Aleks Radovic-Moreno (Longwood Fund), Dan Janney (Alta Partners)
Kynexis
Series ANov 2023$61M
$61M
Rampart Bioscience
Series AOct 2023$85M
$85M
Co-investors: David Bonita (OrbiMed)
Complement Therapeutics
Series AApr 2023$79M
SeedFeb 2022$6M
$85M
Co-investors: Max Klement (BGV (BioGeneration Ventures)), Geert-Jan Mulder (Forbion), Anne Horgan (Cambridge Innovation Capital)
Seamless Therapeutics
SeedMar 2023$13M
$13M
Gyroscope Therapeutics
Series CMar 2021$150M
$210M
Co-investors: Robert Tansley (Cambridge Innovation Capital), Wouter Joustra (Forbion), Maha Katabi (Sofinnova Investments)
Bachelor Student HotmailPresent
Master Student BayerPresent
Research Scientist (PhD student) HotmailPresent
Data Management antibodies-onlinePresent
Research Scientist (PostDoc) HotmailPresent
Head of Laboratory (Ophthalmology) BayerPresent
Project Leader/Alliance Manager BayerPresent
Director, Early Licensing, Global Business Development BayerPresent
Senior Director, Global Business Development & Licensing BayerPresent
Senior Associate ForbionPresent
Board Observer VectorYPresent
Principal ForbionPresent
Board Observer Gyroscope TherapeuticsPresent
Board Member OxularPresent
Board Member RyCarma TherapeuticsPresent
Board Member HotmailPresent
Board Member Complement TherapeuticsPresent
Board Member Seamless TherapeuticsPresent
Board Member KynexisPresent
Board Member AAVantgardePresent
Board Member Rampart BiosciencePresent
Board Member Beacon TherapeuticsPresent
Board Member Mosanna TherapeuticsPresent
Partner ForbionPresent
General Partner ForbionPresent
RWTH Aachen University Bachelor of Science (BS) Biotechnology
RWTH Aachen University Dr. rer. nat. (PhD) Biotechnology; Immunology